ADVANTAGE THERAPEUTICS
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease. The company is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.
ADVANTAGE THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2021-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.advantagetherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
305-846-9027
Total Funding:
15.22 M USD
Technology used in webpage:
Cloudflare Hosting
Similar Organizations
Advaite
Advaite develops a therapeutic and diagnostic solution for cancer.
Aperture Therapeutics
Aperture Therapeutics develops novel therapies for neurodegenerative diseases, leveraging genetic diversity.
Braegen Pharmaceutical
The company is developing drugs for neurodegenerative diseases including Alzheimer’s disease.
Enobia Pharma
Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.
North Coast Biologics
North Coast Biologics develops technologies antibodies treating infectious and autoimmune diseases.
Palisade Therapeutics
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
Telocyte
Telocyte is a biotechnology company dedicated to curing Alzheimer's disease.
Current Advisors List
Founder
Official Site Inspections
http://www.advantagetherapeutics.com Semrush global rank: 13.36 M Semrush visits lastest month: 78
- Host name: 172.67.203.246
- IP address: 172.67.203.246
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ADvantage Therapeutics"
About Klothea Bio Inc. - advantagetherapeutics.com
Nov 26, 2024 Klothea Bio Secures Funding from Longevitytech.fund as a lead investor to Pioneer BreakthroughTreatments for Metabolic Syndrome and several Aging-Associated …See details»
ADvantage Therapeutics - Crunchbase Company …
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.See details»
ADvantage Therapeutics Inc. - Org Chart, Teams, Culture & Jobs
View ADvantage Therapeutics Inc.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ADvantage Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for ADvantage Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Advantage Therapeutics - Overview, News & Similar companies
Www.advantagetherapeutics.com. Revenue <$5 Million. Industry Hospitals & Clinics Healthcare . Recent News & Media. No recent news or media. Overview ; Who is Advantage Therapeutics. …See details»
ADvantage Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Oct 26, 2023 Explore ADvantage Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
ADvantage Therapeutics Has Commenced Enrollment for Its Phase …
Nov 11, 2023 www.advantagetherapeutics.com. About AD04™ ADvantage Therapeutics is developing AD04™ as a novel therapy for mild Alzheimer’s Disease. The compound has been …See details»
Advantage Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Advantage Therapeutics Inc. of Fort Lauderdale, FL. Get the latest business insights from Dun & Bradstreet.See details»
Advantage Therapeutics - VentureRadar
Website: https://advantagetherapeutics.com/ ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s ...See details»
ADvantage Therapeutics Has Commenced Enrollment for Its Phase …
MIAMI, Nov. 27, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), a pioneer in developing therapies for neurodegenerative conditions by …See details»
ADvantage Therapeutics - Company Profile - Tracxn
Oct 19, 2024 ADvantage Therapeutics ranks 85th among 186 active competitors. 68 of its competitors are funded while 33 have exited. Overall, ADvantage Therapeutics and its …See details»
ADvantage Therapeutics taking disruptive approach to mild …
May 16, 2023 Closely-held ADvantage Therapeutics is awaiting regulatory approval in Europe to proceed with a Phase 2b confirmatory clinical trial of its lead drug candidate, AD04, for the …See details»
Discoverer of the Klotho Gene and Pioneer in Longevity and …
Feb 5, 2024 About fifty million people worldwide suffer from Alzheimer’s Disease, which is the sixth leading cause of death in industrialized countries. In 2019, the World Health Organization …See details»
ADvantage Therapeutics Developing Therapies to Treat
Mar 15, 2023 According to the World Health Organization, total worldwide cost of dementia was estimated to be $1.3 trillion in 2019. ... [email protected] (305) 846-9027 195 …See details»
ADvantage Therapeutics, Inc. (ADvantage Therapeutics, Inc.) - 药物 …
For more information, please contact: Jeffrey Madden, CEOADvantage Therapeutics, Inc.195 NW 40th StreetMiami, FL [email protected] 临床2期 高管变更 100 项与 …See details»
ADvantage Therapeutics Inc. - Facebook
ADvantage Therapeutics Inc. 1 like. ADvantage is a clinical stage pharmaceutical company focused on the development of therapeutics for patients suffering from neurodegenerative diseaseSee details»
OUR TEAM - Advantage Therapeutics
This Privacy Policy governs the manner in which ADvantage Therapeutics Inc. (“ ADvantage Therapeutics,” “ we,” or “ us ”) collects, uses, maintains and ...See details»
ADvantage Therapeutics Developing Therapies to Treat ... - BioSpace
Mar 15, 2023 According to the World Health Organization, total worldwide cost of dementia was estimated to be $1.3 trillion in 2019. While the FDA provisionally approved an anti-amyloid …See details»
ADvantage Therapeutics Has Commenced Enrollment for Its Phase …
Dec 1, 2023 ADvantage Therapeutics is dedicated to advancing the science of neurodegenerative diseases and committed to developing innovative therapies that can make …See details»